Bioventus Class A financial statements

바이오벤투스NASDAQ:BVS · Nasdaq · Healthcare · sector #16
$13.10-3.11%
2026-10-06 close · prelim

Bioventus Class A's published financial data is dated 2026-10-04. 2024 revenue was $573M. 2024 operating profit was −$12M.

Reported results

Bioventus Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q